VISTARIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vistaril, and what generic alternatives are available?
Vistaril is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in VISTARIL is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vistaril
A generic version of VISTARIL was approved as hydroxyzine hydrochloride by CHARTWELL RX on April 12th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VISTARIL?
- What are the global sales for VISTARIL?
- What is Average Wholesale Price for VISTARIL?
Summary for VISTARIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,913 |
| Drug Prices: | Drug price information for VISTARIL |
| What excipients (inactive ingredients) are in VISTARIL? | VISTARIL excipients list |
| DailyMed Link: | VISTARIL at DailyMed |
Recent Clinical Trials for VISTARIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sultan Qaboos University | Phase 4 |
| University of Colorado, Denver | N/A |
| Stanford University | N/A |
Pharmacology for VISTARIL
| Drug Class | Antihistamine |
| Mechanism of Action | Histamine Receptor Antagonists |
US Patents and Regulatory Information for VISTARIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | VISTARIL | hydroxyzine pamoate | CAPSULE;ORAL | 011459-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | VISTARIL | hydroxyzine hydrochloride | INJECTABLE;INJECTION | 011111-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | VISTARIL | hydroxyzine pamoate | CAPSULE;ORAL | 011459-004 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
